Direxion Daily NVDA Bull... NVDU - 옵션 체인 | ADVFN

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
ETFs
미국
NASDAQ
Direxion Daily NVDA Bull 2X ETF (NVDU)
Direxion Daily NVDA Bull 2X ETF (NVDU) 옵션

Direxion Daily NVDA Bull 2X ETF (NVDU)

56.17

-7.34

(-11.56%)

마감 07 3월 6:00AM

57.15

0.98

( 1.74% )

시간외 단일가: 9:24PM

NVDU 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
47.00	11.10	12.30	14.02	11.70	-9.28	-39.83 %	1	1	06/03/2025
48.00	10.40	11.90	17.00	11.15	0.00	0.00 %	0	2	-
49.00	9.20	11.00	0.00	10.10	0.00	0.00 %	0	0	-
50.00	8.70	10.20	16.00	9.45	0.00	0.00 %	0	106	-
51.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
52.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
53.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
54.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
55.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
56.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
57.00	5.00	6.50	6.70	5.75	-5.80	-46.40 %	29	0	07/03/2025
58.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
59.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
60.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
61.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
62.00	3.50	4.30	4.50	3.90	0.00	0.00 %	3	15	07/03/2025
63.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
64.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
65.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
66.00	2.20	3.00	2.89	2.60	-3.61	-55.54 %	38	46	07/03/2025

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
47.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
48.00	1.00	3.50	2.80	2.25	0.75	36.59 %	3	5	07/03/2025
49.00	2.60	3.70	2.04	3.15	0.00	0.00 %	0	53	-
50.00	2.40	4.50	3.37	3.45	1.37	68.50 %	70	180	07/03/2025
51.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
52.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
53.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
54.00	4.00	5.40	5.00	4.70	0.00	0.00 %	0	15	-
55.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
56.00	4.90	6.60	6.15	5.75	2.15	53.75 %	1	13	07/03/2025
57.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
58.00	6.10	7.90	4.70	7.00	0.00	0.00 %	0	32	-
59.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
60.00	7.30	9.30	8.22	8.30	2.92	55.09 %	17	110	07/03/2025
61.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
62.00	9.40	10.60	10.14	10.00	2.94	40.83 %	3	13	07/03/2025
63.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
64.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
65.00	10.70	13.00	7.72	11.85	0.00	0.00 %	0	172	-
66.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
SUNESUNation Energy Inc	US$ 0.4683 (164.43%)	101.04M
PSTVPlus Therapeutics Inc	US$ 2.22 (54.17%)	15.75M
HFBLHome Federal Bancorp Inc of Louisiana	US$ 19.85 (53.88%)	5
BBGIBeasley Broadcast Group Inc	US$ 9.99 (53.46%)	37
VTVTvTv Therapeutics Inc	US$ 25.00 (49.88%)	4
LUNRIntuitive Machines Inc	US$ 7.14 (-36.59%)	1.46M
SYRESpyre Therapeutics Inc	US$ 13.01 (-36.54%)	69
PROVProvident Financial Holdings Inc	US$ 11.20 (-24.78%)	18
USCBUSCB Financial Holdings Inc	US$ 14.20 (-20.89%)	12
BFINBankFinancial Corporation	US$ 10.21 (-20.48%)	25
SUNESUNation Energy Inc	US$ 0.4683 (164.43%)	101.04M
FAMIFarmmi Inc	US$ 0.3179 (39.06%)	35.41M
PSTVPlus Therapeutics Inc	US$ 2.22 (54.17%)	15.75M
CTMXCytomX Therapeutics Inc	US$ 0.7751 (25.56%)	15.54M
ICONIcon Energy Corporation	US$ 0.154 (6.21%)	6.93M

ubueltp

ubueltp 31 초 전

As Naz is going door to door looking to sell, word is out and valuations become more internally concrete. I expect the share price to increase, as interest and expectations turns into share price increases. GLTL….it’s coming

chereb19

chereb19 32 초 전

No shares, yet you’re still churning this whiny MK soap opera? ‘Five patients aren’t thriving’? December 2024 says they’re recovering well—metastatic or not, that’s the safety win, not your pity party. ‘Underdosed’ flawing Phase 1? Spare us—FDA’s pre-subs see that India data, Phase 2’s on, safety’s

JOoa0ky

JOoa0ky 42 초 전

Not with Mark Calabria the whale hunter around.

KISSINGER

KISSINGER 1 분 전

This is a fantasy world your living here. Maybe he will merge one of his shitty horses in the shell. Or maybe he chould name one of his foals Bad Vibrations and put it in this POS. A R Merger may get an initial run but it will die fast and it will be a disaster for people buying here except on an in

RickNagra

RickNagra 2 분 전

Calling all whales.

Chip79

Chip79 2 분 전

StayHumble continues to post the same miss-leading information on a daily basis. The real facts are:

>Kevin Lamb does not work for UBQU, he is a VP at Gentell

>Long term debt has grown fom 1.1M in 2023, to 2.4M in 2024. Overall liabilities jumped from 1.6M to 4.2M

StayHumble

StayHumble 2 분 전

💹Major US Xchange✅$HCWC InfoDeck💹✅💹https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
https://investorshub.advfn.com/uimage/uploads/2025/2/23/ijjizHCMC_screenshot_2.png
h

gladeshawk

gladeshawk 2 분 전

QS>>>Fyi on solid state batteries. QS has a chance to be the pick for VW EVs. Just a FYI.

https://www.msn.com/en-us/news/technology/anode-free-solid-state-batteries-could-provide-more-than-500-miles-of-ev-range-on-a-charge/ar-AA1AhRdK?ocid=msedgdhp&pc=DCTS&cvid=821486d608b84aaca1e9c

bucks2pennies

bucks2pennies 2 분 전

Yes can, GTCH future still a BIG can of worms! Still cannot but feel the mess is unwinding more and more each day. Progress in doing so, IMO, gives more strength to our perspective that GTCH continues to have "REAL" value in addition to their holdings of AVAI and BNIX.

It seems they

Hoskuld

Hoskuld 3 분 전

I don't invest that way and I assume other people don't invest that way either. Tesla is a car company. Maybe it wants to be a robot company. The car company is worth $40b. The robot company is worth the other $$850b? I don't think so.

Truthsocial

Truthsocial 4 분 전

FINAL WARNING.....ON RDGL

https://www.nolo.com/legal-encyclopedia/libel-vs-slander-different-types-defamation.html

IRON_CROSS

IRON_CROSS 5 분 전

Long road left to hoe from here, but at least the .07-.09 gaps finally got filled. That's one helluva chart 👇️ ... nasty.

https://investorshub.advfn.com/uimage/uploads/2025/3/7/lkecqScreen_Shot_2025-03-07_at_7.19.56_AM.png

https://investorshub.advfn.com/uimage/

StayHumble

StayHumble 5 분 전

wow💹$DJT launching $100+💹PE Ratio is +475 Facts Matter🇺🇸Maybe

StayHumble

StayHumble 5 분 전

💹$HYCM💹on the SILVER screen✅the GoldenGlobe✅💹

$7.00 or Nothing

$7.00 or Nothing 6 분 전

IB_ is a SHE?

Wow - I can't imagine it - sorry - it does not work for me...

rodman

rodman 6 분 전

The race to market is on and the big boy Pfizer cannot bully UEEC!
CelluSTAT Hemostatic Gauze IS the proven hemostasis product.
Gel and foam will need to jump many hurdles and pass many FDA obstacles!

https://clinicaltrials.gov/search?cond=hemostat&viewType=Table&checkSp

tulla236a

tulla236a 7 분 전

are there cracks starting in the dam? if they can tap into finra and the dtcc records too that would destroy those 2.

https://x.com/xMarketNews/status/1897755482753765633

SC8

Apparently human trial standards are lower in India than USA. FDA was emphatic that effective dosages be worked out before they would authorize human trials. It appears RDGL is still messing with dosages and Indian authorities gave green light to phase 2 anyway.

Again, we know FDA i

Roofus

Roofus 8 분 전

They are compared to if Betaglue had been treating them.

$7.00 or Nothing

$7.00 or Nothing 8 분 전

Making it CLEAR once and for all:
when a company is bought or merges with another company, do all partnerships with financial implication need to be disolved?
Not necessarily! When a company is bought or merges with another, the fate of its financial partnerships depends on several fac

work-n-hard

work-n-hard 8 분 전

MLGO: In https://investorshub.advfn.com/uimage/uploads/2025/3/7/cvtwlScreenshot_2025-03-07_at_07-30-46_MLGO_SharpCharts_StockCharts.com.png

europa7

europa7 8 분 전

"...usdc on @hedera is live on @cryptocom..."

HBAR Foundation
@HBAR_foundation
Mar 7, 2025
https://x.com/HBAR_foundation/status/1897947502436888594

"...usdc on @hedera is live on @cryptocom..."

https://x.com/cryptocom
*&#x

elks

What y’all say where is a good play at?

stocktowatch

stocktowatch 9 분 전

$CVM CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
https://finance.yahoo.com/news/cel-sci-reports-fiscal-q1-133000994.html

KISSINGER

KISSINGER 9 분 전

ZENADRONE Benefits from Chinese tariffs?? You need to be in business to benefit. ZENA is only in the business of fluff, hype and lies.

This POS is going to buite it hard just like EPAZD and all the other PASSLEY deals before it. Arent you embarassed Shaun?? Probably not since you hav

Direxion Daily NVDA Bull...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관